Isolated testicular leukemic relapse response to radiation therapy
dc.contributor.author | Amendola, Beatriz E. | en_US |
dc.contributor.author | Hutchinson, Raymond J. | en_US |
dc.contributor.author | Barton Grossman, H. | en_US |
dc.contributor.author | Amendola, Marco A. | en_US |
dc.date.accessioned | 2006-04-07T20:01:19Z | |
dc.date.available | 2006-04-07T20:01:19Z | |
dc.date.issued | 1987-09 | en_US |
dc.identifier.citation | Amendola, Beatriz E., Hutchinson, Raymond, Barton Grossman, H., Amendola, Marco A. (1987/09)."Isolated testicular leukemic relapse response to radiation therapy." Urology 30(3): 240-243. <http://hdl.handle.net/2027.42/26922> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6VJW-4CT0X5V-J1/2/a65d7d0824c0b4078eb24d65e7d1d5ff | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/26922 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3477044&dopt=citation | en_US |
dc.description.abstract | Between January, 1975, and December, 1984, at the University of Michigan Medical Center, 17 boys with leukemia presented with overt or occult isolated testicular relapse. Diagnosis was obtained by bilateral open-wedge biopsies of the testes. All the patients were treated with combined local testicular irradiation and systemic chemotherapy. In only 1 of the 17 patients (6 %) testicular leukemia developed as the only site of relapse. It appears that doses in the range of 2,000 to 2,400 cGy in 10 to 12 fractions achieve optimum control of leukemic infiltration of the testes. | en_US |
dc.format.extent | 408362 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Isolated testicular leukemic relapse response to radiation therapy | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Departments of Radiation Oncology, Pediatrics (Hematology Division), Surgery (Urology Section), and Radiology, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Departments of Radiation Oncology, Pediatrics (Hematology Division), Surgery (Urology Section), and Radiology, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Departments of Radiation Oncology, Pediatrics (Hematology Division), Surgery (Urology Section), and Radiology, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Departments of Radiation Oncology, Pediatrics (Hematology Division), Surgery (Urology Section), and Radiology, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 3477044 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/26922/1/0000488.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0090-4295(87)90243-3 | en_US |
dc.identifier.source | Urology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.